I
Exchange
—
Entity type
operating
Fiscal year end
Dec 31
Headquarters
DE
Recent Filings
- 8-K515.8 KBINTERCEPT PHARMACEUTICALS, INC.Nov 8, 4:44 PM ET·0001104659-23-115782
- 10-Q10.4 MBINTERCEPT PHARMACEUTICALS, INC.Nov 6, 5:15 PM ET·0001558370-23-017790
- SC 13G/A13.1 KBINTERCEPT PHARMACEUTICALS, INC.Oct 10, 11:07 AM ET·0001104659-23-108028
- 8-K1.0 MBINTERCEPT PHARMACEUTICALS, INC.Sep 26, 8:28 AM ET·0001104659-23-103739
- 10-Q10.0 MBINTERCEPT PHARMACEUTICALS, INC.Aug 2, 4:01 PM ET·0001558370-23-012896
- 8-K353.1 KBINTERCEPT PHARMACEUTICALS, INC.Aug 2, 7:05 AM ET·0001104659-23-086579
- SC 13G/A13.1 KBINTERCEPT PHARMACEUTICALS, INC.Jul 10, 10:41 AM ET·0001104659-23-079463
- SC 13G/A13.6 KBINTERCEPT PHARMACEUTICALS, INC.Jul 7, 4:35 PM ET·0001306550-23-009566
- 8-K271.3 KBINTERCEPT PHARMACEUTICALS, INC.Jun 23, 6:35 AM ET·0001104659-23-073996
- 8-K219.0 KBINTERCEPT PHARMACEUTICALS, INC.Jun 22, 8:50 PM ET·0001104659-23-073909
Insiders
10- Adorini LucianoChief Scientific Officer
- AKKARAJU SRINIVASDirector
- BALL BRYANChief Quality Officer
- Benatti LucaDirector
- Berrey M MichellePresident, R&D and CMO
- BRADBURY DANIELDirector
- Campagna JasonChief Medical Officer
- Cawkwell GailSVP, Med Affairs, Safety & PV
- DeFrancesco LisaSVP, IR & Corp. Affairs
- Duncan Barbara GayleChief Financial Officer
Tickers
No tickers on record
Addresses
business
305 MADISON AVENUE
MORRISTOWN, NJ, 07960
mailing
305 MADISON AVENUE
MORRISTOWN, NJ, 07960
Former Names
- INTERCEPT PHARMACEUTICALS INC2018-04-12